| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anti-BCMA/GPRC5D bispecific CAR T cells for relapsed or refractory multiple myeloma: is 1 + 1 greater than 2?
|
Li, Chenggong
|
|
|
11 |
10 |
p. e712-e713
|
article
|
| 2 |
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
|
Zhou, Dian
|
|
|
11 |
10 |
p. e751-e760
|
article
|
| 3 |
Association and small risk from low-dose radiation exposure
|
Lee, Won Jin
|
|
|
11 |
10 |
p. e713-e715
|
article
|
| 4 |
Blood cancer: the bold dancer
|
Philpotts, Eleanor
|
|
|
11 |
10 |
p. e726-e727
|
article
|
| 5 |
Blood cell defence against pathogens
|
Abrams, Simon T
|
|
|
11 |
10 |
p. e728
|
article
|
| 6 |
Correction to Lancet Haematol 2024; 10: e879–89
|
|
|
|
11 |
10 |
p. e723
|
article
|
| 7 |
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
|
Harrison, Claire N
|
|
|
11 |
10 |
p. e729-e740
|
article
|
| 8 |
Equivalence in clinical assessment of iron status requires ferritin assay standardisation before harmonisation of ferritin reference intervals
|
Swinkels, Dorine W
|
|
|
11 |
10 |
p. e721
|
article
|
| 9 |
Isatuximab plus carfilzomib–dexamethasone for relapsed multiple myeloma
|
Maruyama, Dai
|
|
|
11 |
10 |
p. e710-e711
|
article
|
| 10 |
Isatuximab plus carfilzomib–dexamethasone versus carfilzomib–dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial
|
Yong, Kwee
|
|
|
11 |
10 |
p. e741-e750
|
article
|
| 11 |
Let's talk about sex and haematopoietic stem-cell transplantation
|
Linke, Andrea
|
|
|
11 |
10 |
p. e724-e725
|
article
|
| 12 |
Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study
|
Leuraud, Klervi
|
|
|
11 |
10 |
p. e761-e769
|
article
|
| 13 |
Lines of the haematology community
|
del Castillo, Jacqueline
|
|
|
11 |
10 |
p. e728
|
article
|
| 14 |
Radiotherapy for haematological malignancies
|
Dee, Edward Christopher
|
|
|
11 |
10 |
p. e721-e722
|
article
|
| 15 |
Sexual health and emotional wellbeing of adolescent and young adult survivors of haematological malignancies
|
Alsuliman, Tamim
|
|
|
11 |
10 |
p. e717-e720
|
article
|
| 16 |
Sexual health and emotional wellbeing of patients with haematological malignancies: general review
|
Alsuliman, Tamim
|
|
|
11 |
10 |
p. e770-e779
|
article
|
| 17 |
Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation
|
Alsuliman, Tamim
|
|
|
11 |
10 |
p. e780-e791
|
article
|
| 18 |
Sexually transmitted infections in the context of haematological malignancies
|
Alsuliman, Tamim
|
|
|
11 |
10 |
p. e792-e802
|
article
|
| 19 |
Should we screen for plasma cell dyscrasias in people with low bone density?
|
Zhukovsky, Sara
|
|
|
11 |
10 |
p. e715-e717
|
article
|
| 20 |
The Lancet Haematology at 10
|
Smith, Lan-Lan
|
|
|
11 |
10 |
p. e709
|
article
|
Journal description